Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
Rang in aandelen #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
Aandeelprijs
$1.05
Marktkapitalisatie
$25.12M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-86.83%
Land
US
Handel Actuate Therapeutics Inc (ACTU)

Categorie

Koersgeschiedenis voor Actuate Therapeutics Inc (ACTU)
Hoogste slotkoers: $1.04 op 2026-08-01

Laagste slotkoers: $8.39 op 2024-08-01
Koersgeschiedenis van Actuate Therapeutics Inc van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -36.39%
2025 -14.02%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH